Bradley Hyman

Scientific Advisor
Bradley Hyman

Bradley Hyman is a leading clinician and researcher in Alzheimer’s disease, focused on the role of genetics and membrane-less organelles in dementia and neurodegeneration.

He is currently the John B. Penny, Jr. Professor of Neurology at Harvard Medical School and director of the Massachusetts Alzheimer’s Disease Research Center. He directs the Alzheimer’s unit at the Mass General Institute for Neurological Disease (MIND), with the goal of understanding the neuropathophysiologic and genetic factors that underlie dementia.

Dr. Hyman’s laboratory studies the anatomical and molecular basis of dementia in Alzheimer’s disease and dementia with Lewy bodies. He also has a clinical practice in the Memory and Disorder Unit at the Massachusetts General Hospital devoted towards the care of patients with dementia.

Dr. Hyman received his M.D. and Ph.D. from University of Iowa, and he has received the Metropolitan Life Award, the Potamkin Prize, an NIH Merit award, and an Alzheimer’s Association Pioneer Award.

Current Affiliation:
Massachusetts General Hospital Harvard Medical School

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science